| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |